Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply

被引：0
|
作者：
Giada Crescioli
Cecilia Lanzi
Guido Mannaioni
Alfredo Vannacci
Niccolò Lombardi
机构：
[1] University of Florence,Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology
[2] Tuscan Regional Centre of Pharmacovigilance,Toxicology Unit and Poison Centre
[3] Careggi University Hospital,undefined
来源：
Internal and Emergency Medicine | 2021年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：799 / 800
页数：1
相关论文
共 50 条
  • [41] Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
    Patocka, Jiri
    Kuca, Kamil
    Oleksak, Patrik
    Nepovimova, Eugenie
    Valis, Martin
    Novotny, Michal
    Klimova, Blanka
    [J]. PHARMACEUTICALS, 2021, 14 (03)
  • [42] Sars-Cov-2 and risk of antiviral drug resistance
    Antonio Vitiello
    [J]. Irish Journal of Medical Science (1971 -), 2022, 191 : 2367 - 2368
  • [43] Sars-Cov-2 and risk of antiviral drug resistance
    Vitiello, Antonio
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (05) : 2367 - 2368
  • [44] PREDICTING ADVERSE DRUG REACTIONS IN HOSPITALISED OLDER PATIENTS: AN EVALUATION OF THE GERONTONET ADVERSE DRUG REACTION (ADR) RISK SCORE
    O'Connor, M. N.
    O'Mahony, D.
    [J]. AGE AND AGEING, 2011, 40 : II69 - II69
  • [45] How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients?
    Bucsa, Camelia
    Farcas, Andreea
    Cazacu, Irina
    Leucuta, Daniel
    Achimas-Cadariu, Andrei
    Mogosan, Cristina
    Bojita, Marius
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (01) : 27 - 33
  • [46] Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
    Sadegh, Sepideh
    Matschinske, Julian
    Blumenthal, David B.
    Galindez, Gihanna
    Kacprowski, Tim
    List, Markus
    Nasirigerdeh, Reza
    Oubounyt, Mhaned
    Pichlmair, Andreas
    Rose, Tim Daniel
    Salgado-Albarran, Marisol
    Spaeth, Julian
    Stukalov, Alexey
    Wenke, Nina K.
    Yuan, Kevin
    Pauling, Josch K.
    Baumbach, Jan
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [47] Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
    Sepideh Sadegh
    Julian Matschinske
    David B. Blumenthal
    Gihanna Galindez
    Tim Kacprowski
    Markus List
    Reza Nasirigerdeh
    Mhaned Oubounyt
    Andreas Pichlmair
    Tim Daniel Rose
    Marisol Salgado-Albarrán
    Julian Späth
    Alexey Stukalov
    Nina K. Wenke
    Kevin Yuan
    Josch K. Pauling
    Jan Baumbach
    [J]. Nature Communications, 11
  • [48] Neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2
    Akhvlediani, Tamar
    Bernard-Valnet, Raphael P.
    Dias, Sara
    Eikeland, Randi
    Pfausler, Bettina
    Sellner, Johann
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3904 - 3912
  • [49] Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients
    Wang, Luhong
    Ding, Yinan
    Zhang, Chuanyong
    Chen, Rong
    [J]. PLOS ONE, 2022, 17 (05):
  • [50] Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients
    Wang, Luhong
    Ding, Yinan
    Zhang, Chuanyong
    Chen, Rong
    [J]. PLOS ONE, 2023, 17 (05):
12345